TMO

NYSE Thermo Fisher Scientific Inc.

Oct 26, 2026 · 8:04 PM ET LAST TRADE Market Closed

$682.16 ↓ -2.73 (-0.40%) Trading Down from the previous close of $684.89, $3.32 below the day’s high of $685.48

YTD change: +17.72%
vs 20-day SMA: +1.50%
vs 200-day SMA: +24.19%

Price ranges

Previous day

$662.50 $677.28

open $672.69 close $673.82

+$1.13 (+0.17%)

Today

$674.37 $685.48

open $676.22 now $682.16

+$5.94 (+0.88%)

Past week

$661.30 $705.79

from $690.00 now $682.16

-$7.84 (-1.14%)

Past month

$635.32 $705.79

from $675.00 now $682.16

+$7.16 (+1.06%)

This year

$435.27 $705.79

from $579.45 now $682.16

+$102.71 (+17.72%)

Price & Performance

+205.78 (+43.97%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 3.3% away from all-time highs of $705.79
TMO is up 18% since the beginning of the year
TMO is up 19% over the past 12 months
TMO is up 1% over the past 1 month
1% of all TMO investors are betting against TMO
Number of investors short TMO has gone down 5% versus last month

TMO reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +19.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $6.68

Earnings momentum +6.4% Quarterly EPS growth

Quarterly change +6.4%

Valuation

P/E ratio 36.39

Enterprise value $285.4B

Beta 0.72

Balance sheet & scale

Income$7.1M

Revenue$47.4B

Cash$6.1B

Debt$41.4M

Income / Debt 0.17×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $252.2B

Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.

Competitor comparison

Ticker	Company	Price	Change
ABT	Abbott Laboratories	$103.70	+1.16%
ISRG	Intuitive Surgical, Inc.	$452.29	+1.90%
MDT	Medtronic Plc	$95.41	-1.22%
BSX	Boston Scientific Corporation	$45.69	-0.70%
EW	Edwards Lifesciences Corporation	$89.07	-1.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.